Key Details
Price
$12.40Annual ROE
-0.30%Beta
1.38Events Calendar
Next earnings date:
Jan 09, 2025Recent quarterly earnings:
Oct 10, 2024Recent annual earnings:
July 30, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
June 07, 2021Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEOG faces intense competition due to the development of new technologies by competitors, which could affect the marketability and profitability of its products.
LANSING, Mich. , Jan. 2, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that, due to U.S. equity markets being closed in observance of the National Day of Mourning for former U.S. President Jimmy Carter, it will now issue its second-quarter earnings release before the opening of the market on Friday, January 10, 2025.
LANSING, Mich. , Nov. 27, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 36th Annual Piper Sandler Healthcare Conference in New York City on Wednesday, December 4, 2024.
LANSING, Mich. , Nov. 5, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12.
Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound.
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.
Neogen (NEOG) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.11 per share a year ago.
Revenue of $217.0 million. Net loss of $12.6 million; $(0.06) per diluted share.
Evaluate the expected performance of Neogen (NEOG) for the quarter ended August 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
FAQ
- What is the primary business of Neogen?
- What is the ticker symbol for Neogen?
- Does Neogen pay dividends?
- What sector is Neogen in?
- What industry is Neogen in?
- What country is Neogen based in?
- When did Neogen go public?
- Is Neogen in the S&P 500?
- Is Neogen in the NASDAQ 100?
- Is Neogen in the Dow Jones?
- When was Neogen's last earnings report?
- When does Neogen report earnings?
- Should I buy Neogen stock now?